Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In VivoAthe Tsibris, Daniel R. Kuritzkes, Bette Korber et al.|PLoS ONE|2009Cited by 233
Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral TherapyPatricia M. Flynn, Jane C. Lindsey, Bret J. Rudy et al.|The Journal of Infectious Diseases|2004Cited by 101
Long-Term Observation of Adolescents Initiating HAART Therapy: Three-Year Follow-UpPatricia M. Flynn, Bret J. Rudy, Jane C. Lindsey et al.|AIDS Research and Human Retroviruses|2007Cited by 65
Randomized Controlled Trial of Feeding a Concentrated Formula to Infants Born to Women Infected by Human Immunodeficiency VirusHarland S. Winter, Jack Moye, James M. Oleske et al.|Journal of Pediatric Gastroenterology and Nutrition|2009Cited by 6
The statistical design and analysis of pandemic platform trials: Implications for the futureChristopher J. Lindsell, Lisa M. LaVange, Prasanna Jagannathan et al.|Journal of Clinical and Translational Science|2024Cited by 2